WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
Generated Narrative: Task template-generated-by-server-phpid-req
version: 1; Last updated: 2019-02-26 00:52:28+0000;
Information Source: http://idmp.who-umc.org/fhir
Profile: Task PhPID request
identifier: http://requester.org/phpidreqid
/123456
status: Requested
intent: proposal
priority: Routine
authoredOn: 2024-09-22
lastModified: 2024-09-22
input
type: Medicinal Product for PhPID request
input
type: Ingredient for PhPID request
input
type: Marketing Auth Holder for PhPID request
value: Organization Acme Inc
Generated Narrative: MedicinalProductDefinition #06cea604-91d0-43cc-8ebe-474d231a83d7
Information Source: http://idmp.who-umc.org/fhir
identifier:
http://ema.europa.eu/example/mpid
/MPID-123type: Medicinal Product
domain: Human use
status: Active
combinedPharmaceuticalDoseForm: tablet
attachedDocument: SPC/123
Contacts
Type Contact Proposed Marketing Authorization Holder/Person Acme Inc name
productName: Marvelol
Usages
Country Jurisdiction Language Netherlands European Union Dutch
Generated Narrative: Ingredient #7db146b5-dfb8-4062-81ba-41b76deafcdc
Information Source: http://idmp.who-umc.org/fhir
Profile: Ingredient (WHO PhP)
status: Active
role: Active
substance
Codes
Concept Methotrexate Strengths
Presentation[x] TextPresentation 1.5 mg (Details: UCUM codemg = 'mg')/1 IU (Details: Strength units applicable in the IDMP PhPID service codeIU = 'arbitrary international unit') 1.5 mg
Generated Narrative: Organization #acmeinc
Information Source: http://idmp.who-umc.org/fhir
Profile: Marketing Authorization Holder
active: true
type: Non-Healthcare Business or Corporation
name: Acme Inc